Buy or sell Counsyl stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Counsyl Stock
Health Technology Company
About Counsyl Stock
Counsyl is a genetic screening and counseling services company. The company provides women and their families with actionable information to guide health decisions. Counsyl operates a clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, and supporting services through Counsyl Complete™, a proprietary suite of solutions, each designed to integrate into clinic workflows and patients’ lives. Their genetic screens provide actionable information to patients and their healthcare providers through process that facilitates clinical decision-making.
The company launched their first commercial screen in 2009, and in January 2018, reached a milestone of having delivered one million patient results.
How Counsyl Works
Source: Counsyl
Investors
Felicis Ventures
Wish, Scopely, Opendoor, Dollar Shave Club, Gusto, Coalition, Plaid, Crusoe Energy Systems, Guild Education, SoundHound
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
Goldman Sachs
WeWork, Alibaba, Spotify, Compass, Pinterest, Bloom Energy, Oscar Health, Circle, Automation Anywhere, Zymergen
Great Oaks Venture Capital
Bolt Financial, Workrise, Collective Health, Acorns, Course Hero, SingleStore, Virta Health, Human Interest, Petal, Plastiq
Funding History
| June 2010 | $7.5M |
|---|---|
| November 2011 | $36.1M |
| August 2012 | $8.2M |
| May 2014 | $50.0M |
Management
Co-Founder & Chief Executive Officer
Ramji Srinivasan
Co-Founder & Chief Science Officer
Eric Evans
Chief Medical Officer
James Goldberg, PhD
Chief Financial Officer
Joel Jung
Chief Commercial Officer
Noah Nasser
Co-Founder & SVP, Technology
Rishi Kacker
Press
hcanews.com - Feb, 2 2018
Business Wire (press release) - Jan, 30 2018
Business Wire (press release) - Jan, 16 2018
Business Wire (press release) - Jan, 4 2018
Business Wire (press release) - Dec, 14 2017
Business Wire (press release) - Dec, 4 2017
GenomeWeb - Nov, 6 2017
Business Wire (press release) - Sep, 11 2017
News-Medical.net - Jul, 25 2017
Business Wire (press release) - Jul, 19 2017
Business Wire (press release) - Jul, 10 2017
Business Wire (press release) - May, 3 2017
Business Wire (press release) - Apr, 26 2017
GenomeWeb - Mar, 29 2017
Business Wire (press release) - Jan, 6 2017
The MIT Technology Review - Mar, 16 2015
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
